Background: We sought to analyze clinical features and surgical results of 10 cases of
| INTRODUCTION
Cardiac myxomas are the most common primary cardiac tumors in adults, accounting for 50% to 70% of the total cardiac tumors. [1] [2] [3] [4] [5] [6] They may be located in both the left and right heart chambers, and can be associated with right ventricular inflow and inferior vena cava obstruction, pulmonary hypertension, mitral regurgitation, congestive heart failure, and acute coronary syndromes. [7] [8] [9] [10] [11] [12] [13] More than 90% of cardiac myxomas are isolated; the remainder, about 7%, occur as a part of a syndrome known as Carney complex (CNC). 14-18 CNC, which was initially reported by Carney et al 19 in 1985 , is an autosomal dominant genetic disorder that is characterized by cardiac myxomas, spotty skin pigmentation, and endocrine secreting tumors. Two-thirds of CNCassociated cardiac myxomas exhibit mutations in PRKAR1A, 20, 21 which has become a reliable means of distinguishing between isolated and CNC myxomas.
In this study, we retrospectively analyzed 574 patients who underwent surgical resection for cardiac myxomas in our medical center over 10 years, and report clinical features and surgical results of 10 cases of cardiac myxomas in CNC.
| MATERIALS AND METHODS

| Patients
The cardiac surgery database of Fuwai Hospital (Beijing, China) was searched for records of all patients who had cardiac myxoma excision during January 2003 to December 2013. All patients with cardiac myxoma were diagnosed by transthoracic echocardiography, chest computed tomography (CT) scan, or magnetic resonance (MR) imaging and were confirmed by postoperative pathological examinations.
Ten patients (out of 574) with cardiac myxoma were diagnosed as CNC according to the inclusion criteria for the diagnosis of CNC (Table 1) . 22 This observational study was approved by our hospital institutional review board.
| Surgical technique
All surgical procedures were performed under cardiopulmonary bypass through a median sternotomy. All the myxomas were excised completely and underwent intraoperative transesophageal echocardiography to detect residual tumors. During the follow-up period, one patient died from a cerebral embolism 40 months after a reoperative resection for a cardiac myxoma. Three (30%) patients had a recurrence of a cardiac myxoma, two patients underwent repeat resection, and one is being followed with serial echos. Two patients underwent re-resection of cardiac myxomas; one patient was under close surveillance without surgery (Table 2 No. 4, 6, 8) . All nine survival patients were in classes I or II of NYHA functional classification.
| Follow-up
| Cardiac myxomas in CNC versus isolated cardiac myxomas
As shown in Table 3 , there was a significant difference in the age between cardiac myxomas in CNC and isolated cardiac myxomas (P = 0.01). The mean age was 32.90 ± 14.37 years in CNC versus 50.30 ± 13.65 years in isolated cardiac myxomas.
There was no significant difference in gender between CNC and isolated cardiac myxomas (P = 0.325). However, the gender ratio of female to male was 4.00 in the cardiac myxomas in CNC, and 1.86 in the isolated cardiac myxomas.
A significant difference was found in the rate of arterial embolism before operations between cardiac myxomas in CNC and isolated cardiac myxomas (P = 0.000). The number of patients with arterial embolism was five (50%) in CNC versus 62 (10.99%) in isolated cardiac myxomas.
There was a significant difference in the rate of multiple cardiac myxomas between CNC and isolated cardiac myxomas (P = 0.000). The number of multiple tumors was seven (70%) in CNC versus 63 (11.17%) in isolated cardiac myxomas.
There was a significant difference in the recurrence rate after resection of cardiac myxoma between CNC and isolated cardiac myxomas (P = 0.002 < 0.05). The number of patients with recurrence after cardiac myxoma resection was three (30%) in CNC and 17 (3.01%) in isolated cardiac myxomas. The incidence of cardiac myxoma recurrence after resection between CNC associated with cardiac myxoma and isolated cardiac myxoma is shown in Figure 1 .
| DISCUSSION
CNC is an autosomal dominant disorder comprising benign mesenchymal tumors including cardiac myxomas, schwannomas, thyroid adenomas, and pituitary adenomas associated with spotty skin pigmentation. A patient is diagnosed with CNC according to the diagnosis criteria of CNC defined by Stratakis et al. 22 The majority of cardiac myxomas occur as an isolated left atrial mass attached to the fossa ovalis, in patients ranging in age from 40 to 60 years old, that is approximately two to three times more prevalent in women than in men, and often do not recur after surgical resection. [23] [24] [25] Few isolated cardiac myxomas may occur in other heart chambers with multiple masses. In contrast to isolated cardiac myxomas, cardiac myxomas in CNC occur in the second or third decade. 14, 19, 20, 26 They are often simultaneously present in multiple heart chambers, and tend to recur both at the initial resection site and/or at distant sites after resection. 16, 19, [27] [28] [29] In the largest genotyped series of CNC patients, 63% were female and 37% were male. 20 Our data revealed a 4:1 female preponderance in CNC cardiac myxomas.
In our study, the mean age of cardiac myxomas in CNC is significantly younger than that of isolated myxomas, which is in agreement with previous studies. Thus, CNC should be suspected in cardiac myxomas in young patients. The most common complication of cardiac myxomas in CNC are arterial embolisms, which occur within 30% of patients. [30] [31] [32] In our group, 50% (5/10) of cardiac myxomas in CNC had arterial embolic events before operation versus 10.99% (62/564) of isolated cardiac myxomas (P < 0.05).
The standard treatment for cardiac myxoma in CNC is surgical resection. Surgery should be performed as soon as the diagnosis of cardiac myxoma is confirmed, in order to prevent emboli, obstructive complications, and sudden death. The surgical mortality is low and long-term prognosis is satisfactory. In isolated cardiac myxomas, surgical treatment is typically curative.
However, patients with CNC showed higher recurrence rates (10-21% vs 4-7% for isolated myxomas). [30] [31] [32] [33] [34] [35] [36] [37] [38] Reasons for relapses include inadequate resections, intraoperative implantation of parts of the tumor, and multi-centric tumor location. 29, 30, 37 In our study, the rate of multiple cardiac myxomas in CNC was significantly higher than that of isolated cardiac myxomas (30% vs 11.17%, P < 0.05). The recurrence rate after resection of cardiac myxomas in CNC was significantly higher than that of isolated cardiac myxomas (30% vs 3.01%, P < 0.05). As shown in Figure 1 , the cardiac myxomas in CNC recur more frequently and at a shorter time after operation. The sites of recurrence of CNC FIGURE 1 Cumulative incidence of cardiac myxomas recurrence during follow-up period. In CNC-cardiac myxomas group, all 10 patients had follow-up echos every year in our center or local hospital until May 2018. During follow-up, three patients had a recurrence diagnosed 24-32 months (mean of 27.67 ± 4.04 months) after their primary operation. In isolated cardiac myxomas group, 17 patients had a recurrence diagnosed 12-81 months (mean of 41.65 ± 23.81 months) after their primary operation. CNC, Carney complex cardiac myxomas can be at the location of the original tumor or in other chambers.
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